Related Experiment Video
Updated: May 3, 2026

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
Tumor-induced perturbations of cytokines and immune cell networks
Brett Burkholder1, Ren-Yu Huang2, Rob Burgess1
1RayBiotech, Inc., 3607 Parkway Lane, Suite 100, Norcross, GA 30092, USA.
Abstract:
Until recently, the intrinsically high level of cross-talk between immune cells, the complexity of immune cell development, and the pleiotropic nature of cytokine signaling have hampered progress in understanding the mechanisms of immunosuppression by which tumor cells circumvent native and adaptive immune responses. One technology that has helped to shed light on this complex signaling network is the cytokine antibody array, which facilitates simultaneous screening of dozens to hundreds of secreted signal proteins in complex biological samples. The combined applications of traditional methods of molecular and cell biology with the high-content, high-throughput screening capabilities of cytokine antibody arrays and other multiplexed immunoassays have revealed a complex mechanism that involves multiple cytokine signals contributed not just by tumor cells but by stromal cells and a wide spectrum of immune cell types. This review will summarize the interactions among cancerous and immune cell types, as well as the key cytokine signals that are required for tumors to survive immunoediting in a dormant state or to grow and spread by escaping it. Additionally, it will present examples of how probing secreted cell-cell signal networks in the tumor microenvironment (TME) with cytokine screens have contributed to our current understanding of these processes and discuss the implications of this understanding to antitumor therapies.
Insights
Tumor cells evade immune responses through complex cytokine signaling. Cytokine antibody arrays reveal how tumor, stromal, and immune cells interact to promote tumor survival and spread, informing new antitumor therapies.
Area of Science:
- Immunology
- Cancer Biology
- Molecular Biology
Background:
- Tumor cells employ complex immunosuppression mechanisms involving intricate immune cell cross-talk and cytokine signaling.
- Understanding these mechanisms has been challenging due to the complexity of immune cell development and pleiotropic cytokine effects.
Purpose of the Study:
- To review the interactions between cancerous, stromal, and immune cells within the tumor microenvironment (TME).
- To summarize key cytokine signals involved in tumor immune evasion and progression.
- To discuss the implications of understanding these cell-cell signaling networks for developing novel antitumor therapies.
Main Methods:
- Utilizing cytokine antibody arrays and other multiplexed immunoassays for high-throughput screening of secreted proteins.
- Integrating high-content screening with traditional molecular and cell biology techniques.
- Analyzing complex cell-cell signaling networks within the TME.
Main Results:
- Tumor immune evasion involves multifaceted cytokine signaling networks contributed by tumor cells, stromal cells, and diverse immune cell types.
- These signals are crucial for tumors to survive immune surveillance in a dormant state or to escape and proliferate.
- Probing TME signaling networks with cytokine screens has significantly advanced the understanding of tumor-immune interactions.
Conclusions:
- The tumor microenvironment is a complex ecosystem with intricate cytokine-mediated communication essential for tumor immune evasion.
- Targeting these specific cytokine signals offers promising avenues for developing effective antitumor therapies.
- Further research into TME signaling networks is critical for overcoming tumor immunosuppression.
Related Concept Videos
The Tumor Microenvironment
The Tumor Microenvironment
Tumor Immunotherapy
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

